Redefining the relevance of established cancer cell lines to the study of mechanisms of clinical anti-cancer drug resistance. - Wikidata - wikimedia - TriplyDB

Redefining the relevance of established cancer cell lines to the study of mechanisms of clinical anti-cancer drug resistance.

Redefining the relevance of established cancer cell lines to the study of mechanisms of clinical anti-cancer drug resistance.

http://www.wikidata.org/entity/Q35558646

about

Bioengineering Models for Breast Cancer Research Molecular and clinical implementations of ovarian cancer mouse avatar models Cancer Cell Line Panels Empower Genomics-Based Discovery of Precision Cancer Medicine Technologies for deriving primary tumor cells for use in personalized cancer therapy Patient-derived xenograft models of breast cancer and their predictive power Current status and evolution of preclinical drug development models of epithelial ovarian cancer Influence of handling conditions on the establishment and propagation of head and neck cancer patient derived xenografts Inherent and acquired resistance to paclitaxel in hepatocellular carcinoma: molecular events involved Prostate cancer stem cell-targeted efficacy of a new-generation taxoid, SBT-1214 and novel polyenolic zinc-binding curcuminoid, CMC2.24 Establishment of highly tumorigenic human colorectal cancer cell line (CR4) with properties of putative cancer stem cells Efficient and simple approach to in vitro culture of primary epithelial cancer cells The Merkel cell polyomavirus minor capsid protein Inference and validation of predictive gene networks from biomedical literature and gene expression data.Malignant extracellular vesicles carrying MMP1 mRNA facilitate peritoneal dissemination in ovarian cancer.How Consistent are Publicly Reported Cytotoxicity Data? Large-Scale Statistical Analysis of the Concordance of Public Independent Cytotoxicity Measurements.Optimization of cell lines as tumour models by integrating multi-omics data.Global Cell Proteome Profiling, Phospho-signaling and Quantitative Proteomics for Identification of New Biomarkers in Acute Myeloid Leukemia Patients Pre-clinical validation of a selective anti-cancer stem cell therapy for Numb-deficient human breast cancers.Modeling platinum sensitive and resistant high-grade serous ovarian cancer: development and applications of experimental systems.Individual patient oesophageal cancer 3D models for tailored treatment.Targeting the Achilles heel of multidrug-resistant cancer by exploiting the fitness cost of resistance.Hydrogel-based 3D model of patient-derived prostate xenograft tumors suitable for drug screening.The RPTEC/TERT1 cell line models key renal cell responses to the environmental toxicants, benzo[a]pyrene and cadmium Patient-derived xenograft models: an emerging platform for translational cancer research Entry tropism of BK and Merkel cell polyomaviruses in cell culture U-251 revisited: genetic drift and phenotypic consequences of long-term cultures of glioblastoma cells.Rapid reprogramming of epigenetic and transcriptional profiles in mammalian culture systems.Assessment of cancer cell line representativeness using microarrays for Merkel cell carcinoma Prediction of resistance to chemotherapy in ovarian cancer: a systematic review.Xenograft assessment of predictive biomarkers for standard head and neck cancer therapies Molecular profiling of tumour budding implicates TGFβ-mediated epithelial-mesenchymal transition as a therapeutic target in oral squamous cell carcinoma.CRABP1 is associated with a poor prognosis in breast cancer: adding to the complexity of breast cancer cell response to retinoic acid.Expression of the multidrug transporter P-glycoprotein is inversely related to that of apoptosis-associated endogenous TRAIL.Establishment and Biological Characterization of a Panel of Glioblastoma Multiforme (GBM) and GBM Variant Oncosphere Cell Lines Cancer drug pan-resistance: pumps, cancer stem cells, quiescence, epithelial to mesenchymal transition, blocked cell death pathways, persisters or what?New mouse xenograft model modulated by tumor-associated fibroblasts for human multi-drug resistance in cancer.Cisplatin resistance: a cellular self-defense mechanism resulting from multiple epigenetic and genetic changes.Targeting of Rac GTPases blocks the spread of intact human breast cancer.Effect of cryopreservation on delineation of immune cell subpopulations in tumor specimens as determinated by multiparametric single cell mass cytometry analysis.Recurrent oral cancer: current and emerging therapeutic approaches.

P2860

Q26770495-724FF905-2598-42C4-A1A7-18AB912D7142 Q26786724-55C5D820-5851-4AC4-9BE2-132B6DB7243E Q26800337-DBA2DECA-1F0D-42B0-8609-C0345638D1EB Q26829581-6B617D0D-72D5-40FD-A3AA-180E338A0484 Q27026531-878C324C-F61F-40F6-8FB2-5D4CCE109051 Q27028117-3B707C0A-1403-418A-BCF4-32D37B70D359 Q27321370-5212386C-B4D7-46DF-A5CA-2707659B73D9 Q28486233-8CD9F23B-C625-4A6F-B2C2-C2469F5D725A Q28533786-75514509-63C6-4D74-B7AF-9BBF857FCE48 Q28539620-488391DA-93D9-4269-9341-7FC4E4DE5091 Q28588419-4394D5EA-5109-4873-AAE8-4B7F95C16BA5 Q28681646-9C973218-D299-43D4-84C7-FA3B080FC631 Q30791224-34252FDC-336D-4ED3-9C0B-5583A3FCE909 Q30841262-75A178F7-4675-4EAC-B0C4-5FE216E86C60 Q31018677-9AE10592-B9F7-49CB-ABC3-2E1EB7EE4DB0 Q31134293-56FB0343-4F23-4B1B-9225-57AB1FF131B7 Q33555287-4F18D83E-566D-473D-9E66-C29AB8F1A1FC Q33626025-A7130F1E-5B86-4332-BC4A-AE3D866F34C7 Q33641924-E01C946C-F5BC-4F46-B09F-7DF7855A30E6 Q33648440-B79EE11D-9ABB-4453-B449-5C60E29E7E1D Q33763765-E61E1012-2568-46E1-9E55-80E4B6960DA4 Q33894635-79E08CAC-5FC2-419C-BA58-C5F7A22ADFD6 Q34025933-EC9CB005-5A17-4F6B-A9E1-8726D062669F Q34205518-7C54541E-BB78-4AE8-ACAE-B159B0976D4F Q34364604-3DC16D14-0FD1-47C0-8C00-F4C423B6CA90 Q35000404-7F160CBF-E720-4DBF-B549-C6416496B69D Q35101229-3AFDC829-1AD5-43B2-9BD8-91550539ECAA Q35196335-2211196F-CD91-4806-801B-362DD4261322 Q35212386-F94C1C2D-EF93-4EFD-8088-48735627B2A7 Q35602135-22990E23-B03E-4A4E-BF6F-028FED2EC8F9 Q35618225-C98D1574-2E5C-421E-B500-0E358CA09584 Q35817482-99EAB49D-1DF9-428F-8630-1F93B090FB9A Q35909089-4A15309B-87B0-49F6-A0B2-AA5D9E5169A2 Q35974087-A45F6E6C-F98B-4D53-8BF1-A404AF39EA87 Q36037500-029BC3FA-8B85-4306-BD3B-C4DD02404C7E Q36094989-6EACD404-D1D0-496F-AB4E-01AF95D9C5E5 Q36105474-13306E8E-7868-4B5A-A66A-962F8230B5B0 Q36234042-4058A0B6-1199-4B59-872C-E730508E1557 Q36266655-44842B33-CE41-4C8A-A497-C0E8793CBAB5 Q36283038-106675B2-C961-43B8-B236-FAF23319ADC5

P2860

Redefining the relevance of established cancer cell lines to the study of mechanisms of clinical anti-cancer drug resistance.

http://www.wikidata.org/entity/Q35558646

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Redefining the relevance of es ...... l anti-cancer drug resistance.

@ast

Redefining the relevance of es ...... l anti-cancer drug resistance.

@en

type

label

Redefining the relevance of es ...... l anti-cancer drug resistance.

@ast

Redefining the relevance of es ...... l anti-cancer drug resistance.

@en

prefLabel

Redefining the relevance of es ...... l anti-cancer drug resistance.

@ast

Redefining the relevance of es ...... l anti-cancer drug resistance.

@en

P1433

Q35558646-86BA2551-FFD5-4362-A56B-D7706D4BE287

P1476

Q35558646-F82C5B5D-B1DF-49E6-BB02-D12C74C15575

P2093

Q35558646-07FF2537-4E11-4DDE-8F15-1C5F9E7758BD

Q35558646-1510667B-B57B-4F95-80F4-36F5200BDDBD

Q35558646-328F3541-4B78-45C8-9B29-AADA8BD471BC

Q35558646-333D95A2-50DC-4938-8FE6-B20841B3ACD1

Q35558646-55F64A0E-A27A-4695-9B70-FAE0019EFBEC

Q35558646-56A926A8-1C64-45BB-A573-0CFD9BFCEAC1

Q35558646-62513CFA-DAF4-4C3D-9103-8BE5E6C46BC8

Q35558646-6B4D9427-30F8-439E-89E5-941855B8AC8A

Q35558646-73E1824D-B412-42C8-8AF5-0B8618518EE0

Q35558646-752DC643-6C0D-4CF5-8EEB-65266551D919

P2860

Q35558646-0102827D-C0D9-47B4-8234-ACEFD66F3FAE

Q35558646-04A32088-95FF-4109-815D-205A38457F32

Q35558646-1D53D2B8-D849-4EB9-B9B1-DD56A609E7CC

Q35558646-2A92A019-4070-4058-A33E-E51DE7E757F1

Q35558646-2DFF44C3-0317-4629-B318-DB7CA3ED54CE

Q35558646-30B682CA-384A-40BC-9978-CB12ADAB0481

Q35558646-316B0E3D-1FC2-4806-BADD-FDC6AD8E8267

Q35558646-3590DE4E-54C8-4FFE-86D0-141D2C04BBD5

Q35558646-36914874-7B86-4305-B0CF-7EB82C82322A

Q35558646-37EF3118-1A77-4C2E-8017-F803858C7BFB

P304

Q35558646-BD29FF20-8360-4239-B1F3-14C15EAA7DDF

P31

Q35558646-73D3FFAF-E22D-4B6D-8056-472312FBDE8E

P356

Q35558646-8191EEF6-8942-4289-8354-44BB5278882E

P407

Q35558646-F6D163C4-9357-4FEA-A12A-06F57F6FF0FE

P433

Q35558646-7DB11491-5FD1-4A4F-BD7B-31364B8C2A16

P478

Q35558646-4006959D-0C0F-4B88-A4F5-009BCD78C506

P50

Q35558646-10D2309E-05D2-4E78-AC9E-A15DBE194311

Q35558646-BA57BC65-D464-4D29-ABCA-09FFFCC072CF

P577

Q35558646-67207A2B-9F49-458F-9B3D-BF21CC8ACC81

P5875

Q35558646-A2CF8259-EDC7-4210-A326-A4AB39D689F7

P698

Q35558646-9DB2F8F3-4FE5-4E6D-AFD7-AA6746B98B17

P932

Q35558646-A96DC3AD-0D10-42D6-85AF-6C96A4CBB976

P356

PNAS.1111840108

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Redefining the relevance of es ...... l anti-cancer drug resistance.

@en

P2093

Anil K Sood

http://www.w3.org/2001/XMLSchema#string

Ben Davidson

http://www.w3.org/2001/XMLSchema#string

Bo R Rueda

http://www.w3.org/2001/XMLSchema#string

Chirayu Patel

http://www.w3.org/2001/XMLSchema#string

Jean-Pierre Gillet

http://www.w3.org/2001/XMLSchema#string

Josiah N Orina

http://www.w3.org/2001/XMLSchema#string

Lisa J Green

http://www.w3.org/2001/XMLSchema#string

Meena I Vora

http://www.w3.org/2001/XMLSchema#string

Michael M Gottesman

http://www.w3.org/2001/XMLSchema#string

Miguel Marino

http://www.w3.org/2001/XMLSchema#string

P2860

A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes

Advances in the molecular detection of ABC transporters involved in multidrug resistance in cancer

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

The NCI60 human tumour cell line anticancer drug screen

Targeting multidrug resistance in cancer

Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy

A gene expression database for the molecular pharmacology of cancer

ABCA3 as a possible cause of drug resistance in childhood acute myeloid leukemia.

The biology of ovarian cancer: new opportunities for translation

Systematic evaluation of three microRNA profiling platforms: microarray, beads array, and quantitative real-time PCR array.

P304

18708-18713

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1111840108

http://www.w3.org/2001/XMLSchema#string

P407

P433

46

http://www.w3.org/2001/XMLSchema#string

P478

108

http://www.w3.org/2001/XMLSchema#string

P50

Anna M. Calcagno

P577

2011-11-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51784713

http://www.w3.org/2001/XMLSchema#string

P698

22068913

http://www.w3.org/2001/XMLSchema#string

P932

3219108

http://www.w3.org/2001/XMLSchema#string